These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND DDIT3, CHOP, 1649, ENSG00000175197, _C/EBP zeta_, MGC4154, GADD153, CHOP10, P35638 AND Treatment
365 results:

  • 1. Prognostic impact of clonal hematopoiesis mutations at complete molecular remission in acute myeloid leukemia with NPM1 mutation.
    Wang L; Shu M; Zhang Z; Dou X; Xu X; Ma Y; Wen L; Yang X; Chen S
    J Cancer Res Clin Oncol; 2024 Oct; 150(10):465. PubMed ID: 39422784
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Cannabinoid combination targets
    Besser E; Gelfand A; Procaccia S; Berman P; Meiri D
    Elife; 2024 Sep; 12():. PubMed ID: 39258755
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Ibrutinib plus rituximab and mini-chop in older patients with newly diagnosed DLBCL: a phase 2 ALLG study.
    Verner E; Johnston A; Pati N; Hawkes EA; Lee HP; Cochrane T; Cheah CY; Filshie R; Purtill D; Sia H; Enjeti AK; Brown C; Murphy N; Curnow J; Lee K; Gandhi MK; Walia M; Butcher BE; Trotman J
    Blood Adv; 2024 Nov; 8(21):5674-5682. PubMed ID: 39226464
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [Antibody-Drug Conjugate for Treating leukemia and Lymphoma-The Present Status, Problems, and Future Development].
    Ida N; Yamauchi T
    Gan To Kagaku Ryoho; 2024 Jul; 51(7):686-690. PubMed ID: 39191681
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Blinatumomab after R-chop bridging therapy for patients with Richter transformation: a phase 2 multicentre trial.
    Guièze R; Ysebaert L; Roos-Weil D; Fornecker LM; Ferrant E; Molina L; Aurran T; Clavert A; de Guibert S; Michallet AS; Saad A; Drénou B; Quittet P; Hivert B; Laribi K; Gay J; Quinquenel A; Broseus J; Rouille V; Schwartz D; Magnin B; Lazarian G; Véronèse L; de Antonio M; Laurent C; Tournilhac O; Pereira B; Feugier P
    Nat Commun; 2024 Aug; 15(1):6822. PubMed ID: 39122717
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Proteasome inhibition induces apoptosis through simultaneous inactivation of MCL-1/BCL-XL by NOXA independent of chop and JNK pathways.
    Chen W; Sun M; Sun Y; Yang Q; Gao H; Li L; Fu R; Dong N
    Toxicology; 2024 Nov; 508():153906. PubMed ID: 39117261
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. [Melatonin Enhances the Effect of ABT-737 in Acute Monocytic leukemia THP-1 Cells].
    Lomovsky AI; Baburina YL; Fadeev RS; Kobyakova MI; Lomovskaya YV; Krestinin RR; Sotnikova LD; Krestinina OV
    Mol Biol (Mosk); 2024; 58(1):141-153. PubMed ID: 38943585
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Ibrutinib combined with immunochemotherapy with or without autologous stem-cell transplantation versus immunochemotherapy and autologous stem-cell transplantation in previously untreated patients with mantle cell lymphoma (TRIANGLE): a three-arm, randomised, open-label, phase 3 superiority trial of the European Mantle Cell Lymphoma Network.
    Dreyling M; Doorduijn J; Giné E; Jerkeman M; Walewski J; Hutchings M; Mey U; Riise J; Trneny M; Vergote V; Shpilberg O; Gomes da Silva M; Leppä S; Jiang L; Stilgenbauer S; Kerkhoff A; Jachimowicz RD; Celli M; Hess G; Arcaini L; Visco C; van Meerten T; Wirths S; Zinzani PL; Novak U; Herhaus P; Benedetti F; Sonnevi K; Hanoun C; Hänel M; Dierlamm J; Pott C; Klapper W; Gözel D; Schmidt C; Unterhalt M; Ladetto M; Hoster E
    Lancet; 2024 May; 403(10441):2293-2306. PubMed ID: 38705160
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. treatment patterns, clinical outcomes and gene mutation characteristics of hepatitis B virus-associated mantle cell lymphoma.
    Feng J; Fei Y; Gao M; Meng X; Zeng D; Zou D; Ye H; Liang Y; Sun X; Liang R; Zhou H; Wang X; Zhang H
    Hematol Oncol; 2024 May; 42(3):e3268. PubMed ID: 38676394
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. CD58 Alterations Govern Antitumor Immune Responses by Inducing PDL1 and IDO in Diffuse Large B-Cell Lymphoma.
    Xu X; Zhang Y; Lu Y; Zhang X; Zhao C; Wang J; Guan Q; Feng Y; Gao M; Yu J; Song Z; Liu X; Golchehre Z; Li L; Ren W; Pan-Hammarström Q; Zhang H; Wang X
    Cancer Res; 2024 Jul; 84(13):2123-2140. PubMed ID: 38635903
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. A multicenter study of venetoclax-based treatment for patients with Richter transformation of chronic lymphocytic leukemia.
    Hampel PJ; Swaminathan M; Rogers KA; Parry EM; Burger JA; Davids MS; Ding W; Ferrajoli A; Hyak JM; Jain N; Kenderian SS; Wang Y; Wierda WG; Woyach JA; Parikh SA; Thompson PA
    Blood Adv; 2024 May; 8(10):2342-2350. PubMed ID: 38537065
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Genetic and transcriptomic analyses of diffuse large B-cell lymphoma patients with poor outcomes within two years of diagnosis.
    Ren W; Wan H; Own SA; Berglund M; Wang X; Yang M; Li X; Liu D; Ye X; Sonnevi K; Enblad G; Amini RM; Sander B; Wu K; Zhang H; Wahlin BE; Smedby KE; Pan-Hammarström Q
    Leukemia; 2024 Mar; 38(3):610-620. PubMed ID: 38158444
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Epigenetic Modulation of ddit3 and MGMT Expression Acts Synergistically with Resistance to Imatinib towards CML Disease Progression: A Hospital based Study.
    Hazarika G; Kalita MJ; Kalita S; Das PP; Dutta K; Lahkar L; Rajkonwar A; Idris MG; Khamo V; Kusre G; Medhi S
    Asian Pac J Cancer Prev; 2023 Dec; 24(12):4059-4069. PubMed ID: 38156838
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Identification of common genes and pathways underlying imatinib and nilotinib treatment in CML: a Bioinformatics Study.
    Hekmatshoar Y; Rahbar Saadat Y; Ozkan T; Bozkurt S; Karadag Gurel A
    Nucleosides Nucleotides Nucleic Acids; 2024; 43(7):664-684. PubMed ID: 38117080
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Synergistic lethality in chronic myeloid leukemia - targeting oxidative phosphorylation and unfolded protein response effectively complements tyrosine kinase inhibitor treatment.
    Häselbarth L; Gamali S; Saul D; Krumbholz M; Böttcher-Loschinski R; Böttcher M; Zou D; Metzler M; Karow A; Mougiakakos D
    BMC Cancer; 2023 Nov; 23(1):1153. PubMed ID: 38012567
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. SOHO State-of-the-Art Updates and Next Questions: treatment for Newly Diagnosed Peripheral T-Cell Lymphomas.
    Burton JS; Foley NC; Mehta-Shah N
    Clin Lymphoma Myeloma Leuk; 2024 Feb; 24(2):65-76. PubMed ID: 37973458
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. [Adult T-cell leukemia/lymphoma].
    Yoshimitsu M
    Rinsho Ketsueki; 2023; 64(9):1032-1040. PubMed ID: 37899180
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Metformin sensitizes AML cells to venetoclax through endoplasmic reticulum stress-chop pathway.
    Hua L; Yang N; Li Y; Huang K; Jiang X; Liu F; Yu Z; Chen J; Lai J; Du J; Zeng H
    Br J Haematol; 2023 Sep; 202(5):971-984. PubMed ID: 37409755
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. The comprehensive expression of BCL2 family genes determines the prognosis of diffuse large B-cell lymphoma.
    Roh J; Pak HK; Jeong S; Hwang S; Kim DE; Choi HS; Kim SJ; Kim H; Cho H; Park JS; Jeong SH; Choi YS; Han JH; Yoon DH; Park CS
    Biochem Biophys Res Commun; 2023 Sep; 673():36-43. PubMed ID: 37356143
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Melatonin Can Enhance the Effect of Drugs Used in the treatment of leukemia.
    Lomovsky AI; Baburina YL; Fadeev RS; Lomovskaya YV; Kobyakova MI; Krestinin RR; Sotnikova LD; Krestinina OV
    Biochemistry (Mosc); 2023 Jan; 88(1):73-85. PubMed ID: 37068876
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 19.